Free Trial

CME Group Inc. (NASDAQ:CME) Shares Bought by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main

CME Group logo with Finance background

DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its position in CME Group Inc. (NASDAQ:CME - Free Report) by 6.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 535,451 shares of the financial services provider's stock after acquiring an additional 32,584 shares during the quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main owned about 0.15% of CME Group worth $124,348,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CME. SJS Investment Consulting Inc. lifted its position in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock valued at $26,000 after buying an additional 97 shares during the period. New Age Alpha Advisors LLC grew its stake in CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners purchased a new stake in CME Group in the fourth quarter valued at approximately $32,000. Knuff & Co LLC purchased a new stake in CME Group during the fourth quarter worth $33,000. Finally, Fortitude Family Office LLC raised its stake in shares of CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock worth $35,000 after buying an additional 83 shares during the period. Hedge funds and other institutional investors own 87.75% of the company's stock.

Insider Activity

In other news, Director Dennis Suskind sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the sale, the director now owns 2,915 shares of the company's stock, valued at approximately $790,781.20. This represents a 25.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Julie Winkler sold 11,592 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. This trade represents a 34.63% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,726 shares of company stock worth $8,975,813 in the last three months. Company insiders own 0.30% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on CME shares. Raymond James upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target for the company in a research report on Monday, March 10th. Piper Sandler upped their price target on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Morgan Stanley raised their price target on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Barclays upped their target price on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a report on Wednesday, April 23rd. Finally, Royal Bank of Canada reissued a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a research note on Thursday, April 3rd. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $256.80.

View Our Latest Report on CME Group

CME Group Stock Up 0.2%

NASDAQ:CME traded up $0.45 on Tuesday, hitting $270.92. The stock had a trading volume of 1,416,765 shares, compared to its average volume of 2,163,479. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The stock has a market cap of $97.63 billion, a P/E ratio of 28.02, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $286.48. The firm's fifty day simple moving average is $264.79 and its two-hundred day simple moving average is $246.09.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter last year, the company posted $2.50 EPS. The business's quarterly revenue was up 10.4% on a year-over-year basis. Analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.85%. The ex-dividend date is Monday, June 9th. CME Group's dividend payout ratio is presently 50.30%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines